Publications

5674 Results

Hypoxia-related markers in the plasma of patients with advanced non-small cell lung cancer (NSCLC) and survival from chemotherapy: Southwest Oncology Group (SWOG) S0003

Authors
IV Galvin;PN Lara;Q Le;K Chansky;JJ Crowley;S Williamson;DR Gandara;PH Gumerlock
Journal / Conference
Proc of the American Society of Clinical Oncology 23:649 (#7146)
Year
2004
Research Committee(s)
Lung
Study Number(s)
S0003

Insulin-like growth factor-I (IGF-1), IGF binding protein-3 (IGFBP-3), and outcome in metastatic colorectal cancer (CRC): Results from Intergroup Trial N9741

Authors
C Fuchs;M Pollak;DJ Sargent;JA Meyerhardt;RK Ramanathan;SK Williamson;B Findlay;E Green;KM Goldberg
Journal / Conference
Proc of the American Society of Clinical Oncology 23:250 (#3521)
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741

N9741: FOLFOX (oxaliplatin (oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study

Authors
RM Goldberg;DJ Sargent;RF Morton;C Fuchs;RK Ramanathan;SK Williamson;BP Findlay;HR Pitot;SR Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 23:275 (#3621)
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741

Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): an update

Authors
TM Habermann;E Weller;VA Morrison;PA Cassileth;J Cohn;S Dakhil;RD Gascoyne;B Woda;R Fisher;BA Peterson;SJ Horning
Journal / Conference
Blood 104(11): #127
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Impact of increased body weight on acute toxicity and outcome of autologous stem cell transplantation for non-Hodgkin's lymphoma: a Southwest Oncology Group analysis

Authors
P Stiff;J Unger;S Forman;M LeBlanc;T Miller;O Press;J Thompson;R Fisher
Journal / Conference
Blood 104(11): #352
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9438

Effect of adding rituximab to three cycles of CHOP plus invoved-field radiotherapy for limited-stage aggressive diffuse B-cell lymphoma (SWOG-0014).

Authors
TP Miller;JM Unger;C Spier;B Stea;E Cantu;M LeBlanc;RI Fisher
Journal / Conference
Blood 104(11): #158
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
S0014

New treatment options have changed the natural history of follicular lymphoma

Authors
RI Fisher;M LeBlanc;OW Press;DG Maloney;TP Miller
Journal / Conference
Blood 104(11): #583
Year
2004
Research Committee(s)
Lymphoma

Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall sirvival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update o fthe results of Intergroup study INT-0116 (SWOG 9008)

Authors
JS Macdonald;S Smalley;J Benedetti;N Estes;DG Haller;JA Ajani;LL Gunderson;M Jessup;JA Martenson
Journal / Conference
American Society of Clinical Oncology GastrointestinaI Cancers Symposium #6
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies

Authors
JM Unger;M LeBlanc;IM Thompson;CA Coltman Jr
Journal / Conference
Urologic Oncology: Seminars and Original Investigations 22:362-368
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

Authors
RC Flanigan;G Mickisch;R Sylvester;C Tangen;H Van Poppel;ED Crawford
Journal / Conference
Journal of Urology 171:1071-1076
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949